Medium materiality6/10
Crinetics downgraded to In Line from Outperform at Evercore ISI
Why it may matterVerify against the original reporting
bearish due to downgrade
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Evercore ISI downgrades Crinetics (CRNX) from Outperform to In Line; current price $83.53; price target $85.
- Downgrade: CRNX to In Line; PT $85; price $83.53.
Key facts
- 01
Target: $85
- 02
Posted price: $83.53
- 03
Analyst firm: Evercore ISI
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.